Cargando…
Nuclear Import of β-Dystroglycan Is Facilitated by Ezrin-Mediated Cytoskeleton Reorganization
The β-dystroglycan (β-DG) protein has the ability to target to multiple sites in eukaryotic cells, being a member of diverse protein assemblies including the transmembranal dystrophin-associated complex, and a nuclear envelope-localised complex that contains emerin and lamins A/C and B1. We noted th...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3944073/ https://www.ncbi.nlm.nih.gov/pubmed/24599031 http://dx.doi.org/10.1371/journal.pone.0090629 |
_version_ | 1782306329897992192 |
---|---|
author | Vásquez-Limeta, Alejandra Wagstaff, Kylie M. Ortega, Arturo Crouch, Dorothy H. Jans, David A. Cisneros, Bulmaro |
author_facet | Vásquez-Limeta, Alejandra Wagstaff, Kylie M. Ortega, Arturo Crouch, Dorothy H. Jans, David A. Cisneros, Bulmaro |
author_sort | Vásquez-Limeta, Alejandra |
collection | PubMed |
description | The β-dystroglycan (β-DG) protein has the ability to target to multiple sites in eukaryotic cells, being a member of diverse protein assemblies including the transmembranal dystrophin-associated complex, and a nuclear envelope-localised complex that contains emerin and lamins A/C and B1. We noted that the importin α2/β1-recognised nuclear localization signal (NLS) of β-DG is also a binding site for the cytoskeletal-interacting protein ezrin, and set out to determine whether ezrin binding might modulate β-DG nuclear translocation for the first time. Unexpectedly, we found that ezrin enhances rather than inhibits β-DG nuclear translocation in C2C12 myoblasts. Both overexpression of a phosphomimetic activated ezrin variant (Ez-T567D) and activation of endogenous ezrin through stimulation of the Rho pathway resulted in both formation of actin-rich surface protrusions and significantly increased nuclear translocation of β-DG as shown by quantitative microscopy and subcellular fractionation/Western analysis. In contrast, overexpression of a nonphosphorylatable inactive ezrin variant (Ez-T567A) or inhibition of Rho signaling, decreased nuclear translocation of β-DG concomitant with a lack of cell surface protrusions. Further, a role for the actin cytoskeleton in ezrin enhancement of β-DG nuclear translocation was implicated by the observation that an ezrin variant lacking its actin-binding domain failed to enhance nuclear translocation of β-DG, while disruption of the actin cytoskeleton led to a reduction in β-DG nuclear localization. Finally, we show that ezrin-mediated cytoskeletal reorganization enhances nuclear translocation of the cytoplasmic but not the transmembranal fraction of β-DG. This is the first study showing that cytoskeleton reorganization can modulate nuclear translocation of β-DG, with the implication that β-DG can respond to cytoskeleton-driven changes in cell morphology by translocating from the cytoplasm to the nucleus to orchestrate nuclear processes in response to the functional requirements of the cell. |
format | Online Article Text |
id | pubmed-3944073 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-39440732014-03-10 Nuclear Import of β-Dystroglycan Is Facilitated by Ezrin-Mediated Cytoskeleton Reorganization Vásquez-Limeta, Alejandra Wagstaff, Kylie M. Ortega, Arturo Crouch, Dorothy H. Jans, David A. Cisneros, Bulmaro PLoS One Research Article The β-dystroglycan (β-DG) protein has the ability to target to multiple sites in eukaryotic cells, being a member of diverse protein assemblies including the transmembranal dystrophin-associated complex, and a nuclear envelope-localised complex that contains emerin and lamins A/C and B1. We noted that the importin α2/β1-recognised nuclear localization signal (NLS) of β-DG is also a binding site for the cytoskeletal-interacting protein ezrin, and set out to determine whether ezrin binding might modulate β-DG nuclear translocation for the first time. Unexpectedly, we found that ezrin enhances rather than inhibits β-DG nuclear translocation in C2C12 myoblasts. Both overexpression of a phosphomimetic activated ezrin variant (Ez-T567D) and activation of endogenous ezrin through stimulation of the Rho pathway resulted in both formation of actin-rich surface protrusions and significantly increased nuclear translocation of β-DG as shown by quantitative microscopy and subcellular fractionation/Western analysis. In contrast, overexpression of a nonphosphorylatable inactive ezrin variant (Ez-T567A) or inhibition of Rho signaling, decreased nuclear translocation of β-DG concomitant with a lack of cell surface protrusions. Further, a role for the actin cytoskeleton in ezrin enhancement of β-DG nuclear translocation was implicated by the observation that an ezrin variant lacking its actin-binding domain failed to enhance nuclear translocation of β-DG, while disruption of the actin cytoskeleton led to a reduction in β-DG nuclear localization. Finally, we show that ezrin-mediated cytoskeletal reorganization enhances nuclear translocation of the cytoplasmic but not the transmembranal fraction of β-DG. This is the first study showing that cytoskeleton reorganization can modulate nuclear translocation of β-DG, with the implication that β-DG can respond to cytoskeleton-driven changes in cell morphology by translocating from the cytoplasm to the nucleus to orchestrate nuclear processes in response to the functional requirements of the cell. Public Library of Science 2014-03-05 /pmc/articles/PMC3944073/ /pubmed/24599031 http://dx.doi.org/10.1371/journal.pone.0090629 Text en © 2014 Vásquez-Limeta et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Vásquez-Limeta, Alejandra Wagstaff, Kylie M. Ortega, Arturo Crouch, Dorothy H. Jans, David A. Cisneros, Bulmaro Nuclear Import of β-Dystroglycan Is Facilitated by Ezrin-Mediated Cytoskeleton Reorganization |
title | Nuclear Import of β-Dystroglycan Is Facilitated by Ezrin-Mediated Cytoskeleton Reorganization |
title_full | Nuclear Import of β-Dystroglycan Is Facilitated by Ezrin-Mediated Cytoskeleton Reorganization |
title_fullStr | Nuclear Import of β-Dystroglycan Is Facilitated by Ezrin-Mediated Cytoskeleton Reorganization |
title_full_unstemmed | Nuclear Import of β-Dystroglycan Is Facilitated by Ezrin-Mediated Cytoskeleton Reorganization |
title_short | Nuclear Import of β-Dystroglycan Is Facilitated by Ezrin-Mediated Cytoskeleton Reorganization |
title_sort | nuclear import of β-dystroglycan is facilitated by ezrin-mediated cytoskeleton reorganization |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3944073/ https://www.ncbi.nlm.nih.gov/pubmed/24599031 http://dx.doi.org/10.1371/journal.pone.0090629 |
work_keys_str_mv | AT vasquezlimetaalejandra nuclearimportofbdystroglycanisfacilitatedbyezrinmediatedcytoskeletonreorganization AT wagstaffkyliem nuclearimportofbdystroglycanisfacilitatedbyezrinmediatedcytoskeletonreorganization AT ortegaarturo nuclearimportofbdystroglycanisfacilitatedbyezrinmediatedcytoskeletonreorganization AT crouchdorothyh nuclearimportofbdystroglycanisfacilitatedbyezrinmediatedcytoskeletonreorganization AT jansdavida nuclearimportofbdystroglycanisfacilitatedbyezrinmediatedcytoskeletonreorganization AT cisnerosbulmaro nuclearimportofbdystroglycanisfacilitatedbyezrinmediatedcytoskeletonreorganization |